Hayley Virgil | Authors


Step Counts Correlated With QoL With SM-88 in Metastatic Pancreatic Cancer

January 16, 2021

Step counts appeared to correlate with self-reported quality of life during the first 2 weeks of treatment with SM-88 in patients with metastatic pancreatic cancer, the results of a preliminary exploratory analysis from part 2 of the phase 2/3 TYME-88-Panc trial showed.

Tucatinib Combo Lengthens Time to Deterioration of HRQoL in HER2+ mBC With Brain Mets

December 12, 2020

Patients with HER2-positive metastatic breast cancer and brain metastases treated with the combination of tucatinib, trastuzumab, and capecitabine had significantly lengthened the time to deterioration of health-related quality of life, according to the results of an analysis of the HER2CLIMB clinical trial presented during the 2020 San Antonio Breast Cancer Symposium.

Adding Atezolizumab to Chemotherapy Improves Patient Outcomes in Early TNBC

December 11, 2020

Pathologic complete responses were improved when neoadjuvant atezolizumab was added to nab-paclitaxel followed by doxorubicin plus cyclophosphamide compared with placebo in combination with chemotherapy as treatment of patients with early triple-negative breast cancer without adding additional treatment burden to patients.